Clinical Trials List
2022-09-01 - 2024-12-20
Phase I
Recruiting4
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chien-Jui Huang Division of General Internal Medicine
- Shang-Yin Wu 未分科
- 劉奕廷 未分科
- 顏志傑 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 何宇傑 Division of Radiation Therapy
- 謝明妤 Division of Otolaryngology
- 曾若涵 Division of Hematology & Oncology
- 林聖皓 Division of Thoracic Medicine
- 李尚儀 Division of Otolaryngology
- 林俊雄 Division of Thoracic Medicine
- 林慶雄 Division of Thoracic Medicine
- 余萬年 Division of Otolaryngology
- 楊繕駿 Division of Radiation Therapy
- 林俊維 未分科
- 林炫聿 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
320 participants
